Branching involved in blood vessel morphogenesis

pathway activity & survival
GO:0001569SurvivalRNA activityKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, RNA activity of the Branching involved in blood vessel morphogenesis pathway is associated with patient survival in 25 of 34 cancer lineages. Pathway activity is summarized from the expression of its 36 member genes.

The strongest signal is observed in uveal melanoma (UVM), where higher Branching involved in blood vessel morphogenesis pathway activity is associated with poorer disease-free survival. In most high-consensus cancer types, elevated pathway activity shows an unfavorable survival association, although some cancer types, such as HNSC and LUAD, show the opposite pattern, with higher activity associated with better survival.

UVM, KIRP, and HNSC are the cancer lineages in which this pathway most reproducibly stratifies patient survival.

Pathway-activity survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 represent the survival AUCs for the high- and low-pathway-activity groups, respectively. The group with the lower AUC is interpreted as having poorer survival. The reported p-values are derived from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
UVMDFSMedianAll0.3500.735<.001135view →
KIRPOSMedianAll0.5810.788<.001108view →
HNSCDFSMedianIV0.4580.296<.00184view →
MESOOSMedianII,III,IV0.2890.513.00243view →
COADDFSTertileAll0.3760.597.00343view →
LGGDFSMedianAll0.2880.462<.00143view →
KICHDFSMedianIII,IV0.3731.000.00941view →
THCAOSTertileII,III,IV0.9451.000<.00140view →
LUADDFSTertileII,III,IV0.7120.313<.00137view →
ACCDFSQuartileII,III,IV0.4870.856.00922view →
OVOSQuartileAll0.2780.394.01520view →
KIRCDFSTertileAll0.5070.688.00416view →
Pink = unfavorable, green = favorable. Showing the 12 strongest of 25 lineages.

GO:0001569–UVM (DFS)

Kaplan–Meier survival curve for Branching involved in blood vessel morphogenesis pathway activity in UVM.

Open the UVM breakdown →

Exploration